TLR9 and hairy cell leukemia: However, a recent study involving ex vivo peripheral blood mononuclear cells (PBMCs) from patients with hairy cell leukemia (HCL) revealed that the cytotoxic effects of venetoclax against HCL cells was significantly reduced following TLR9 stimulation with CpG (62).